Oral nanomedicine may bring relief for Kala-Azar

Patients affected by Kala- Azar, scientifically called Visceral leishmaniasis (VL), one of the most neglected tropical diseases may soon find relief in an oral nanomedicine from India. The oral therapeutics could help in the control and elimination of VL, around 95 % of which is reported from Bangladesh, Brazil, China, Ethiopia, India, Kenya, Nepal, Somalia, South Sudan, and Sudan. Scientists of Mahali based the Institute of Nano Science & Technology under the Department of Science & Technology have developed this Nanomedicine.